References:
- F. Bray, J. Ferlay, I. Soerjomataram, et
al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries CA Cancer J.
Clin., 68 (6) (2018), pp. 394-424.
- Osses DF, Roobol MJ, Schoots IG. Prediction Medicine: Biomarkers, Risk
Calculators and Magnetic Resonance Imaging as Risk Stratification
Tools in Prostate Cancer Diagnosis. Int J Mol Sci .
2019;20(7):1637.
- Mottet, N.; Bellmunt, J.; Bolla, M.; Briers, E.; Cumberbatch, M.G.; De
Santis, M.; Fossati, N.; Gross, T.; Henry, A.M.; Joniau, S.; et al.
Eau-estro-siog guidelines on prostate cancer. Part 1: Screening,
diagnosis, and local treatment with curative intent. Eur. Urol. 2017,
71, 618–629.
- Jiang H, Li H, Li A, et al. Preoperative combined hemoglobin, albumin,
lymphocyte and platelet levels predict survival in patients with
locally advanced colorectal cancer. Oncotarget .
2016;7(44):72076-72083.
- McMillan DC. Systemic inflammation, nutritional status and survival in
patients with cancer. Curr Opin Clin Nutr Metab
Care. 2009;12:223–226.
- Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of nutritional and
inflammatory status of advanced colorectal cancer patients and its
correlation with survival. Nutr Cancer. 2006;55:78–85.
- Guo Y, Shi D, Zhang J, et al. The Hemoglobin, Albumin, Lymphocyte, and
Platelet (HALP) Score is a Novel Significant Prognostic Factor for
Patients with Metastatic Prostate Cancer Undergoing Cytoreductive
Radical Prostatectomy. J Cancer . 2019;10(1):81-91.
- Peng D, Zhang C, Tang Q, Zhang L, Yang K, Yu X. et al. Prognostic
significance of the combination of preoperative hemoglobin and albumin
levels and lymphocyte and platelet counts (HALP) in patients with
renal cell carcinoma after nephrectomy. BMC Urol. 2018;18:20.
- Peng D, Zhang C, Gong Y, Hao H, Guan B, Li X. et al. Prognostic
significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in
patients with bladder cancer after radical cystectomy. Sci Rep.
2018;8:794.
- Chen X, Xue L, Wang W, Chen H, Zhang W, Liu K. et al. Prognostic
significance of the combination of preoperative hemoglobin, albumin,
lymphocyte and platelet in patients with gastric carcinoma: a
retrospective cohort study. Oncotarget. 2015;6:41370–82.
- Jiang H, Li H, Li A, Tang E, Xu D, Chen Y. et al. Preoperative
combined hemoglobin, albumin, lymphocyte and platelet levels predict
survival in patients with locally advanced colorectal cancer.
Oncotarget. 2016;7:72076–83.
- Lukes M, Urban M, Záleský M, Zachoval R, Herácek J, Zdárský E.
Prostate-specific antigen: current status. Folia Biol (Praha) .
2001;47(2):41-49.
- Nassir AM. A piece in prostate cancer puzzle: Future perspective of
novel molecular signatures. Saudi J Biol Sci .
2020;27(4):1148-1154.
- Salami SS, Schmidt F, Laxman B, et al. Combining urinary detection of
TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate
cancer. Urol Oncol . 2013;31(5):566-571.
- Milanese G, Dellabella M, Fazioli F, et al. Increased urokinase-type
plasminogen activator receptor and epidermal growth factor receptor in
serum of patients with prostate cancer. J Urol .
2009;181(3):1393-1400.
- Yuksel OH, Urkmez A, Akan S, Yldirim C, Verit A. Predictive Value of
the Platelet-To-Lymphocyte Ratio in Diagnosis of Prostate
Cancer. Asian Pac J Cancer Prev . 2015;16(15):6407-6412.
- Kaynar M, Yildirim ME, Gul M, Kilic O, Ceylan K, Goktas S. Benign
prostatic hyperplasia and prostate cancer differentiation via platelet
to lymphocyte ratio. Cancer Biomark . 2015;15(3):317-323.
- Adhyatma KP, Warli SM. Diagnostic Value of Platelet-To-Lymphocyte
Ratio in Prostate Cancer. Open Access Maced J Med Sci .
2019;7(7):1093-1096.
- Wang J, Zhou X, He Y, et al. Prognostic role of platelet to lymphocyte
ratio in prostate cancer: A meta-analysis. Medicine
(Baltimore) . 2018;97(40):e12504.
- Adhyatma KP, Prapiska FF, Siregar GP, Warli SM. Systemic Inflammatory
Response in Predicting Prostate Cancer: The Diagnostic Value of
Neutrophil-To-Lymphocyte Ratio. Open Access Maced J Med Sci .
2019;7(10):1628-1630.
- Fu S, Zhang X, Niu Y, Wang RT. Prostate Specific Antigen, Mean
Platelet Volume, and Platelet Distribution Width in Combination to
Discriminate Prostate Cancer from Benign Prostate
Hyperplasia. Asian Pac J Cancer Prev . 2018;19(3):699-702.
- Cong L, Hu L. The value of the combination of hemoglobin, albumin,
lymphocyte and platelet in predicting platinum-based chemoradiotherapy
response in male patients with esophageal squamous cell
carcinoma. Int Immunopharmacol . 2017;46:75-79.
- Shen XB, Zhang YX, Wang W, Pan YY. The Hemoglobin, Albumin,
Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung
Cancer Before First-Line Treatment with Etoposide and Progression-Free
Survival. Med Sci Monit . 2019;25:5630-5639.
- Xu SS, Li S, Xu HX, et al. Haemoglobin, albumin, lymphocyte and
platelet predicts postoperative survival in pancreatic
cancer. World J Gastroenterol . 2020;26(8):828-838.
- Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer
Anaemia Survey (ECAS): a large, multinational, prospective survey
defining the prevalence, incidence, and treatment of anaemia in cancer
patients. Eur J Cancer . 2004;40(15):2293-2306.
- Jain S, Harris J, Ware J. Platelets: linking hemostasis and
cancer. Arterioscler Thromb Vasc Biol . 2010;30(12):2362-2367.
- Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related
inflammation. Nature . 2008;454(7203):436-444.
- Wang C, Guo M, Zhang N, Wang G. Association of body mass index and
outcomes following lobectomy for non-small-cell lung
cancer. World J Surg Oncol . 2018;16(1):90.
- Sejima T, Iwamoto H, Masago T, et al. Low pre-operative levels of
serum albumin predict lymph node metastases and ultimately correlate
with a biochemical recurrence of prostate cancer in radical
prostatectomy patients. Cent European J Urol .
2013;66(2):126-132.
- Michaud JE, Billups KL, Partin AW. Testosterone and prostate cancer:
an evidence-based review of pathogenesis and oncologic
risk. Ther Adv Urol . 2015;7(6):378-387.
Legends:
Table-1: The patient characteristics and laboratory
results
Table-2: Comparision of the parameters for ROC analysis
Figure-1: The ROC analysis of the parameters